GL1X · GenesisL1 explorer

MolNFT v1 · #182055 · protein

Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 ha trimer

7MFG · Hemagglutinin HA1 chain: “Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex…”. Electron microscopy, 2 ligands (NAG, BMA), 20 pockets (best druggability 0.72). MolNFT v1…

PDB
7MFG
Type
protein
Length
2,121 residues
Chains
12
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin HA1 chain; Hemagglutinin HA2 chain; 310-030-1D06 heavy; 310-030-1D06 light
UniProt
Q6WG00, Q289M7
Ligands
NAG, BMA
Pockets
20 · best druggability 0.72

Structure

electron microscopy · 4 distinct chains · 18% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, GHemagglutinin HA1 chainprotein32211% helix, 34% strandQ6WG00
B, D, IHemagglutinin HA2 chainprotein15755% helix, 10% strandQ289M7
H, E, J310-030-1D06 heavyprotein1205% helix, 37% strand—
L, F, K310-030-1D06 lightprotein1080% helix, 37% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 27 copies · chains B, D, I, A, C, G
  • BMA · beta-D-mannopyranose · sugar · 3 copies · chains L, F, K

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15430.720.8056empty
23900.710.8252empty
35170.700.8057empty
43030.660.8247empty
52960.660.8247empty

Interfaces

27 interfaces between chains.

  • C–D · 2590 Ų buried · 37 hydrogen bonds · protein-protein
  • A–B · 2581 Ų buried · 38 hydrogen bonds · protein-protein
  • G–I · 2580 Ų buried · 34 hydrogen bonds · protein-protein
  • D–I · 945 Ų buried · 9 hydrogen bonds · protein-protein
  • B–D · 942 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 27 disulfide, 24 glycan (disulfide, N-glycosylation).

Compared structures

  • 7MFG · Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.